Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota

Overview

About this study

The purpose of this study is to describe a serial of clustered plasma cell dyscrasia cases in northern Minnesota by describing the disease characteristics, including disease presentations, treatments, and outcomes.  To describe the familial and geographic relationships between clustered plasma cell dyscrasia cases and the common environmental exposures.  Identify the association between exposure and plasma cell dyscrasia development

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years or older
  • Confirmed diagnosis of multiple myeloma (MM), Waldenstrom macroglobulinemia (WM) or monoclonal gammopathy of undetermined significance (MGUS)
  • Agreement in consent and participate in a short interview

Exclusion Criteria:

  • Refusal or inability to consent for the study

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sundararajan Rajkumar, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20306930

Mayo Clinic Footer